Olmesartan Medoxomil & Hydrochlorothiazide Tablets

Olmesartan Medoxomil & Hydrochlorothiazide Tablets

Product Name :

Ramipril Xr Tablets 7.5mg Tablet

Available Strength :

Ramipril 7.5 mg

Packing :

3x10 Alu-Alu Blister / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antihypertensive therapy

Production Capacity :

10 Million Tablets/Month

Description:

What is Olmesartan Medoxomil & Hydrochlorothiazide Tablets?

Olmesartan Medoxomil and Hydrochlorothiazide Tablets are an oral combination antihypertensive formulation containing an angiotensin II receptor blocker and a thiazide diuretic. Available strengths include 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg, and the combination is used for blood pressure management according to approved product information.

Uses / Indications

  • Used for the management of hypertension.
  • May be used when treatment with an angiotensin II receptor blocker and a diuretic is clinically appropriate.
  • Different strengths provide options based on blood pressure response and treatment requirements.
  • Use should follow the approved product information and the recommendation of a qualified healthcare professional.

Benefits

  • Combines two complementary antihypertensive mechanisms in a single tablet.
  • Supports blood pressure management through angiotensin II receptor blockade and increased urinary sodium and water excretion.
  • Available in multiple strength combinations.
  • Convenient oral tablet formulation for prescribed hypertension treatment.

Side Effects

Common Side Effects

Possible side effects may include:

  • Dizziness
  • Headache
  • Fatigue
  • Increased urination
  • Gastrointestinal discomfort
  • Mild changes in blood electrolyte levels

Less Common or Serious Side Effects

Clinically significant reactions may include excessive reduction in blood pressure, changes in kidney function, electrolyte disturbances, increased uric acid, increased blood glucose, or increased potassium levels.

Seek medical attention for severe dizziness or fainting, significant weakness, irregular heartbeat, severe allergic symptoms, marked reduction in urine output, or other serious symptoms.

How Does It Work?

Olmesartan Medoxomil is converted to olmesartan, which blocks the angiotensin II AT1 receptor. This reduces vasoconstriction and aldosterone-mediated effects, helping lower blood pressure.

Hydrochlorothiazide is a thiazide diuretic that increases the excretion of sodium and water by the kidneys. This reduces fluid volume and contributes to lowering blood pressure.

Dosage Guidelines

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

The appropriate strength may depend on blood pressure, previous treatment, renal function, electrolyte status, other medicines, and individual clinical circumstances.

Take the tablet exactly as prescribed and swallow it with water. Do not crush, chew, or split the tablet unless permitted by the approved product information.

Because hydrochlorothiazide is a diuretic, the timing of administration should follow the prescribed instructions.

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

When Not to Use

This combination should not be used in individuals with known hypersensitivity to olmesartan, hydrochlorothiazide, sulfonamide-derived medicines where clinically relevant, or any component of the formulation.

It should not be used during pregnancy unless specifically directed by an appropriate healthcare professional, as medicines acting on the renin-angiotensin system can cause fetal harm.

It is also unsuitable in certain patients with severe kidney impairment or inability to produce urine, depending on the specific clinical circumstances.

Drug / Product Interactions

Potential interactions may occur with:

  • Other antihypertensive medicines
  • Potassium supplements or potassium-containing salt substitutes
  • Potassium-sparing diuretics
  • Medicines affecting serum potassium
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Lithium
  • Medicines that may alter blood glucose or uric acid levels
  • Other diuretics or medicines affecting fluid and electrolyte balance

The complete medication list should be reviewed by a qualified healthcare professional before treatment.

Safety Advice

  • Use only according to the prescribed or approved treatment instructions.
  • Monitor blood pressure as advised.
  • Kidney function and electrolytes may require monitoring during treatment.
  • Maintain appropriate fluid intake unless a healthcare professional has advised fluid restriction.
  • Rise slowly from sitting or lying positions if dizziness occurs.
  • Inform the healthcare professional about kidney disease, liver disease, gout, diabetes, or electrolyte disorders.
  • Report severe weakness, persistent dizziness, irregular heartbeat, or significant reduction in urine output.
  • Inform the healthcare professional promptly if pregnancy occurs.

General Instructions

  • Take the tablet exactly as directed.
  • Maintain the prescribed dosing schedule.
  • Swallow the tablet with water.
  • Do not take more than the prescribed amount.
  • Do not share the medicine with another person.
  • Continue regular blood-pressure monitoring as advised.
  • Keep the product in its original packaging where possible.

Special Dietary / Lifestyle Tips

  • Follow a balanced diet appropriate for blood-pressure management.
  • Moderate dietary sodium intake according to healthcare advice.
  • Maintain regular physical activity appropriate to individual health status.
  • Maintain adequate hydration unless fluid restriction has been advised.
  • Limit excessive alcohol consumption.
  • Maintain a healthy body weight where appropriate.
  • Patients with diabetes or gout should follow individualized dietary guidance from their healthcare professional.

Comparison with Other Treatments

Olmesartan Medoxomil and Hydrochlorothiazide combine an angiotensin II receptor blocker with a thiazide diuretic in one tablet. Other hypertension regimens may use either component alone or combine different classes of antihypertensive medicines. Treatment selection depends on blood pressure, kidney function, electrolyte status, concurrent conditions, other medicines, and approved prescribing information.

Precautions & Warnings

  • Monitor kidney function and serum electrolytes when clinically appropriate.
  • Hydrochlorothiazide can affect sodium, potassium, calcium, glucose, and uric acid levels.
  • Use caution in patients with kidney impairment, gout, diabetes, or conditions associated with electrolyte disturbances.
  • Excessive fluid loss may contribute to dizziness or low blood pressure.
  • Excessive sun exposure may increase the risk of photosensitivity reactions associated with hydrochlorothiazide.
  • Inform the healthcare professional about all prescription medicines, over-the-counter products, and supplements.
  • Pregnancy should be reported promptly because of the risks associated with medicines acting on the renin-angiotensin system.

Can I Use It With Other Medicines?

Generally Compatible With

Other medicines may be used with this combination when specifically prescribed after review of the patient’s complete medication profile and blood-pressure treatment requirements.

Use With Caution / Avoid

Particular caution may be required with:

  • Potassium supplements and potassium-containing salt substitutes
  • Potassium-sparing diuretics
  • Lithium
  • NSAIDs
  • Other diuretics
  • Medicines affecting blood glucose or uric acid
  • Other medicines that substantially lower blood pressure

A qualified healthcare professional should review all concurrent medicines before treatment.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

Keep the tablets in their original packaging, protected from excessive heat and moisture, and out of reach of children. Do not use the product after the stated expiry date.

Frequently Asked Questions

1. What is Olmesartan Medoxomil & Hydrochlorothiazide Tablets used for?

This combination is used for the management of hypertension when treatment with an angiotensin II receptor blocker and a diuretic is considered appropriate.

2. What strengths are available?

The listed strengths are 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg of Olmesartan Medoxomil and Hydrochlorothiazide, respectively.

3. What are the active ingredients?

The tablets contain Olmesartan Medoxomil and Hydrochlorothiazide as the active ingredients.

4. Does Hydrochlorothiazide increase urination?

Hydrochlorothiazide promotes the excretion of sodium and water through the kidneys, which can increase urination, particularly after starting treatment.

5. Can this medicine affect potassium levels?

Yes. Hydrochlorothiazide and olmesartan can both influence electrolyte balance. The direction and extent of potassium changes can vary between individuals, so monitoring may be appropriate for patients at risk.

6. Can this medicine affect blood sugar or uric acid?

Hydrochlorothiazide may affect glucose and uric acid levels in some individuals. Patients with diabetes or gout should inform their healthcare professional before and during treatment.

7. Can I stop taking this medicine when my blood pressure improves?

Do not stop prescribed antihypertensive treatment without consulting a qualified healthcare professional. Improved blood pressure may reflect the effect of ongoing treatment.

8. How should these tablets be stored?

Store according to the conditions stated on the approved product label and package insert. Keep the product protected from excessive heat and moisture and out of reach of children.

Scroll to Top